AbbVie Inc. (ABBV): EPS (Basic)
$2.37
Year ended 2025-12-31
-29.1%
3-year compound annual growth
-2.8%
5-year compound annual growth
-2.8%
10-year compound annual growth
| Period ended | EPS (Basic) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.37 | -1.3% | 2026-02-20, From 2025-01-01 |
| 2024-12-31 | $2.40 | -12.1% | 2026-02-20, From 2024-01-01 |
| 2023-12-31 | $2.73 | -58.9% | 2026-02-20, From 2023-01-01 |
| 2022-12-31 | $6.65 | +2.6% | 2025-02-14, From 2022-01-01 |
| 2021-12-31 | $6.48 | +137.4% | 2024-02-20, From 2021-01-01 |
| 2020-12-31 | $2.73 | -48.5% | 2023-02-17, From 2020-01-01 |
| 2019-12-31 | $5.30 | +44.4% | 2022-02-18, From 2019-01-01 |
| 2018-12-31 | $3.67 | +10.9% | 2021-02-19, From 2018-01-01 |
| 2017-12-31 | $3.31 | -9.3% | 2020-02-21, From 2017-01-01 |
| 2016-12-31 | $3.65 | +15.9% | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | $3.15 | +183.8% | 2018-02-16, From 2015-01-01 |
| 2014-12-31 | $1.11 | -57.0% | 2017-02-17, From 2014-01-01 |
| 2013-12-31 | $2.58 | -23.0% | 2016-02-19, From 2013-01-01 |
| 2012-12-31 | $3.35 | +53.7% | 2015-02-20, From 2012-01-01 |
| 2011-12-31 | $2.18 | n/a | 2014-02-21, From 2011-01-01 |
EPS (Basic) at similar companies
| Company | Year ended | EPS (Basic) | Change YoY |
|---|---|---|---|
| AbbVie Inc. (ABBV) | 2025-12-31 | $2.37 | -1.3% |
| Pfizer Inc (PFE) | 2025-12-31 | $1.37 | -3.5% |
| Merck & Co., Inc. (MRK) | 2025-12-31 | $7.30 | +8.0% |
| Eli Lilly & Co (LLY) | 2025-12-31 | $23.00 | +95.6% |
| Bristol Myers Squibb Co (BMY) | 2025-12-31 | $3.47 | n/m |
| Abbott Laboratories (ABT) | 2025-12-31 | $3.73 | -51.4% |
| Johnson & Johnson (JNJ) | 2025-12-28 | $11.13 | +90.6% |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $1.23 | n/m |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $43.07 | +5.3% |
Compare ABBV, PFE, MRK, LLY side by side · Screen every company in Pharmaceutical Preparations ↗